Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Asterasys CoXKRX:450950 -4.29%23 Median PS Value is ₩0.00 as of Sep. 03, 2026. GuruFocus rates XKRX:450950 with a GF Score™ of 23/100. The stock has 4 warning signs investors should review. Among 340 Medical Devices & Instruments companies, Asterasys Co ranks worse than 294117.35% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Asterasys Co's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 was ₩1054.546. Asterasys Co's 10-Year median PS Ratio is 0. Therefore, the Median PS Value for today is ₩0.00.
As of today (2026-09-03), Asterasys Co's share price is ₩5130.00. Asterasys Co's Median PS Value is ₩0.00. Therefore, Asterasys Co's Price to Median PS Value for today is 0.00.
The historical rank and industry rank for Asterasys Co's Median PS Value or its related term are showing as below:
XKRX:450950's Price-to-Median-PS-Value is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 0.71 * Ranked among companies with meaningful Price-to-Median-PS-Value only.
Asterasys Co (XKRX:450950) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Asterasys Co's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
5130.00
/
0.00
=
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Asterasys Co Median PS Value Related Terms
Asterasys Co Median PS Value Historical Data
* Premium members only.
The historical data trend for Asterasys Co's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKRX:450950 vs ABT, SYK, MDT: Median PS Value Comparison
For the Medical Devices subindustry, Asterasys Co's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Asterasys Co Price-to-Median-PS-Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Asterasys Co's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Asterasys Co's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 0.
Asterasys Co's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩1054.546.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Asterasys Co (XKRX:450950) has a Median PS Value of ₩0.00 as of Sep. 03, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Asterasys Co and its competitors. According to the industry distribution chart, Asterasys Co ranks #999999 out of 340 companies in the Medical Devices & Instruments industry.
Is Asterasys Co's Median PS Value too high?
Asterasys Co's current Median PS Value is ₩0.00. Based on the distribution chart, Asterasys Co ranks #999999 out of 340 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Asterasys Co has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Asterasys Co's Median PS Value compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Asterasys Co ranks #999999 out of 340 companies for Median PS Value. This places Asterasys Co in the lower half of its industry. The industry median Median PS Value is 0.71. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Medical Devices & Instruments company?
The median Median PS Value among Medical Devices & Instruments companies is 0.71, based on 340 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Asterasys Co and its competitors. For the Medical Devices & Instruments industry, the median Median PS Value is 0.71 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Asterasys Co's current Median PS Value is ₩0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Asterasys Co stock overvalued right now?
Asterasys Co (XKRX:450950) has a current Median PS Value of ₩0.00. The current Median PS Value is ₩0.00. Asterasys Co's overall GF Score™ is 23/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Asterasys Co (XKRX:450950), the current Median PS Value is ₩0.00 as of Sep. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Asterasys Co Ltd is a professional healthcare and biomedical corporation based in Korea. It is engaged in the Manufacture of electro-diagnostic and electro-therapeutic apparatuses featuring body composition analyzers such as the InBalance series and HIFU systems such as the Liftera series, it provides total solutions with healthcare, skincare, and IoT-oriented services that can connect with its product portfolio.
23GF Score
Get the complete analysis for XKRX:450950
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKRX:450950 has been successfully added to your 
